Skip to main content
. 2023 Jun 21;57(5):1050–1061. doi: 10.1007/s43441-023-00543-z

Table 2.

PVA-level analysis: most common data exchange days for clinical trial ICSRs with related fatal/life-threatening SAEs reported by member companies

Member company to partner Partner to member company
Total number of PVAs 246 245
Most common exchange days (ascending order) 4, 5 4, 5
Percent of PVAs with exchange on most common exchange days 79% 79%